Health Economics Research Institute, Sun Yat-Sen University, Guangdong, China.
Shanghai VMLY&Rx Co., Ltd., Shanghai, China.
Medicine (Baltimore). 2022 Dec 23;101(51):e32304. doi: 10.1097/MD.0000000000032304.
There is a myriad of microwave ablation (MWA) systems used in clinical settings worldwide for the management of liver cancer that offer a variety of features and capabilities. However, an analysis on which features and capabilities result in the most favorable efficacy and safety results has never been completed due to a lack of head-to-head comparisons. The aim of this study is to compare single-antenna and multiple-antenna MWA using radiofrequency ablation (RFA) as a common comparator in the treatment of very-early, early hepatocellular carcinoma (HCC) and ≤5 cm liver metastases.
This network meta-analysis was performed according to PRISMA guidelines. PubMed, Cochrane, and Web of Science databases were searched for comparative studies. Complete ablation (CA) rate, local tumor progression-free (LTPF) rate, overall survival (OS), and major complication rate were assessed. Subgroup analyses were further performed based on synchronous or asynchronous MWA generators and tumor size (<2 cm or ≥2 cm).
Twenty-one studies (3424 patients), including 3 randomized controlled trials (RCTs) and 18 observational studies, met eligibility criteria. For CA, LTPF and major complications, as compared to single-antenna MWA, multiple-antenna MWA had relative risks (RRs) of 1.051 (95% CI: 0.987-1.138), 1.099 (95% CI: 0.991-1.246), and 0.605 (95% CI: 0.193-1.628), respectively. For 1-year and 3-year OS, as compared to single-antenna MWA, multiple-antenna MWA had odds ratios (ORs) of 0.9803 (95% CI: 0.6772-1.449) and 1.046 (95% CI: 0.615-1.851), respectively. Subgroup analysis found synchronized multi-antenna MWA was associated with significantly better LTPF by 22% (RR: 1.22, 95% CI 1.068, 1.421), and 21.4% (RR: 1.214, 95% CI 1.035, 1.449) compared with single-antenna MWA, and asynchronous multiple-antenna MWA, respectively, with more evident differences in larger tumors (≥2 cm).
Multi-antenna and single-antenna MWA showed similar effectiveness for local treatment of liver tumors, but synchronous multi-antenna MWA exhibited better LTPF compared to other MWA approaches, particularly for larger liver tumors (≥2 cm). Large-scale RCTs should be further conducted.
在全球范围内,有许多种用于肝癌治疗的微波消融(MWA)系统,这些系统具有不同的特点和功能。然而,由于缺乏头对头的比较,还从未对哪些特点和功能能够带来最有利的疗效和安全性结果进行过分析。本研究旨在比较单天线和多天线 MWA 与射频消融(RFA),并将其作为一种常见的比较器,用于治疗非常早期和早期肝细胞癌(HCC)以及≤5cm 肝转移瘤。
本网络荟萃分析按照 PRISMA 指南进行。在 PubMed、Cochrane 和 Web of Science 数据库中检索比较研究。评估完全消融(CA)率、局部肿瘤无进展(LTPF)率、总生存率(OS)和主要并发症发生率。进一步根据同步或异步 MWA 发生器和肿瘤大小(<2cm 或≥2cm)进行亚组分析。
符合入选标准的有 21 项研究(3424 例患者),包括 3 项随机对照试验(RCT)和 18 项观察性研究。与单天线 MWA 相比,多天线 MWA 在 CA、LTPF 和主要并发症方面的相对风险(RR)分别为 1.051(95%CI:0.987-1.138)、1.099(95%CI:0.991-1.246)和 0.605(95%CI:0.193-1.628)。与单天线 MWA 相比,多天线 MWA 在 1 年和 3 年 OS 方面的优势比(OR)分别为 0.9803(95%CI:0.6772-1.449)和 1.046(95%CI:0.615-1.851)。亚组分析发现,与单天线 MWA 相比,同步多天线 MWA 的 LTPF 更好,其差异分别为 22%(RR:1.22,95%CI 1.068-1.421)和 21.4%(RR:1.214,95%CI 1.035-1.449),且在较大肿瘤(≥2cm)中差异更为明显。
多天线和单天线 MWA 对肝脏肿瘤的局部治疗效果相似,但同步多天线 MWA 与其他 MWA 方法相比,具有更好的 LTPF,尤其是对于较大的肝脏肿瘤(≥2cm)。应进一步开展大规模 RCT 研究。